Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

75%

3 trials in Phase 3/4

Results Transparency

100%

4 of 4 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

Phase 4

3(75.0%)

N/A

1(25.0%)

4Total

Phase 4(3)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT01260272Not ApplicableCompleted

Study of Raisins Versus Alternative Snacks on Cardiovascular Risk Factors In Generally Healthy Subjects

Role: lead

NCT01677936Phase 4Completed

Study of Raisins Versus Alternative Snacks in Patients With Type 2 Diabetes Mellitus

Role: lead

NCT01062269Phase 4Completed

A Single Research Site Bile Acid Sequestrant Acceptability (BASA) Scale Pilot Validation Study

Role: lead

NCT01122108Phase 4Completed

Comparison of Colesevelam Hydrogen Chloride (HCl) Powder For Oral Suspension Versus Generic Cholestyramine Through Use of the Bile Acid Sequestrant Acceptability (BASA) Scale

Role: lead

All 4 trials loaded